Aytu Bioscience (AYTU) could be a great investment
What’s up with Aytu Bioscience?
Aytu Bioscience(AYTU) opened at $1.70, which means the stock is down 9.66% from yesterday’s closing price of 1.76. Today, the company has a high of $1.70 and a low of $1.55. The stock holds a market cap of $92.51 million which is not impressive since the P/E ratio is -1.11. The company has a 52-week high of $2.99 and a 52-week low of $0.34.
What is P/E ratio?
The price-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of a company’s share price to the company’s earnings per share. The ratio is used for valuing companies and to find out whether they are overvalued or undervalued. Aytu Bioscience has a weak.A negative PE ratio means that a stock has negative earnings. In other words, the company was losing money in the past 12 months.
About Aytu Bioscience
Aytu BioScience, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.